These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 36302085)

  • 1. Using single-cell multi-omics screening of human fetal pancreas to identify novel players in human beta cell development.
    Olaniru OE; Hook P; Persaud SJ
    Diabet Med; 2022 Dec; 39(12):e14992. PubMed ID: 36302085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols.
    Liew CG
    Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redefining the signaling pathways from pluripotency to pancreas development: In vitro β-cell differentiation.
    Hashemitabar M; Heidari E
    J Cell Physiol; 2019 Jun; 234(6):7811-7827. PubMed ID: 30480819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
    Triolo TM; Bellin MD
    Front Endocrinol (Lausanne); 2021; 12():636824. PubMed ID: 33776933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of human pluripotent stem cell-derived pancreatic β-like cells in the mouse pancreas.
    Ma H; Wert KJ; Shvartsman D; Melton DA; Jaenisch R
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3924-3929. PubMed ID: 29599125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pluripotent stem cell based islet models for diabetes research.
    Balboa D; Otonkoski T
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):899-909. PubMed ID: 26696518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From pluripotent stem cells to bioengineered islets: A challenging journey to diabetes treatment.
    Carvalho AM; Nunes R; Sarmento B
    Eur J Pharm Sci; 2022 May; 172():106148. PubMed ID: 35189271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
    Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
    Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
    Cierpka-Kmiec K; Wronska A; Kmiec Z
    Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding cell fate acquisition in stem-cell-derived pancreatic islets using single-cell multiome-inferred regulomes.
    Zhu H; Wang G; Nguyen-Ngoc KV; Kim D; Miller M; Goss G; Kovsky J; Harrington AR; Saunders DC; Hopkirk AL; Melton R; Powers AC; Preissl S; Spagnoli FM; Gaulton KJ; Sander M
    Dev Cell; 2023 May; 58(9):727-743.e11. PubMed ID: 37040771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in generation of human surrogate β cells.
    Efrat S
    Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):259-64. PubMed ID: 23807600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Eye as a Transplantation Site to Monitor Pancreatic Islet Cell Plasticity.
    Ilegems E; Berggren PO
    Front Endocrinol (Lausanne); 2021; 12():652853. PubMed ID: 33967961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Differentiation of Pluripotent Stem Cells into Functional β Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets.
    Bose B; Sudheer PS
    Methods Mol Biol; 2016; 1341():257-84. PubMed ID: 25783769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differentiation of pluripotent stem cells into pancreatic lineages].
    Mfopou JK; Bouwens L
    Med Sci (Paris); 2013; 29(8-9):736-43. PubMed ID: 24005628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection for CD26
    Molakandov K; Berti DA; Beck A; Elhanani O; Walker MD; Soen Y; Yavriyants K; Zimerman M; Volman E; Toledo I; Erukhimovich A; Levy AM; Hasson A; Itskovitz-Eldor J; Chebath J; Revel M
    Front Endocrinol (Lausanne); 2021; 12():635405. PubMed ID: 34025576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise Review: Markers for Assessing Human Stem Cell-Derived Implants as β-Cell Replacement in Type 1 Diabetes.
    Pipeleers D; Robert T; De Mesmaeker I; Ling Z
    Stem Cells Transl Med; 2016 Oct; 5(10):1338-1344. PubMed ID: 27381993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
    Dadheech N; James Shapiro AM
    Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-culture with mature islet cells augments the differentiation of insulin-producing cells from pluripotent stem cells.
    Oh BJ; Oh SH; Choi JM; Jin SM; Shim WY; Lee MS; Lee MK; Kim KW; Kim JH
    Stem Cell Rev Rep; 2015 Feb; 11(1):62-74. PubMed ID: 25173880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regenerative medicine: using liver to generate pancreas for treating diabetes.
    Meivar-Levy I; Ferber S
    Isr Med Assoc J; 2006 Jun; 8(6):430-4. PubMed ID: 16833177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.